JNJ
Johnson & Johnson
- Stock-based compensation, FY2025
- $1.4B
- YoY, FY2025
- +15.1%
- 5-year CAGR
- +6.1%
- 10-year CAGR
- +4.5%
Stock-based compensation
Stock-based compensation by fiscal year
| Period | Stock comp | YoY |
|---|---|---|
| FY2025 | $1.4B | +15.1% |
| FY2024 | $1.2B | +1.2% |
| FY2023 | $1.2B | +2.1% |
| FY2022 | $1.1B | +0.3% |
| FY2021 | $1.1B | +12.9% |
| FY2020 | $1.0B | +2.9% |
| FY2019 | $977M | −0.1% |
| FY2018 | $978M | +1.7% |
| FY2017 | $962M | +9.6% |
| FY2016 | $878M | +0.5% |
| FY2015 | $874M | +10.4% |
| FY2014 | $792M | +8.8% |
| FY2013 | $728M | +10.0% |
| FY2012 | $662M | +6.6% |
| FY2011 | $621M | +1.1% |
| FY2010 | $614M | −2.2% |
| FY2009 | $628M | +0.2% |
| FY2008 | $627M | −10.2% |
| FY2007 | $698M | — |